A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality

被引:14
作者
Maignen, Francois [1 ]
Hauben, Manfred [2 ,3 ]
Dogne, Jean-Michel [4 ]
机构
[1] Off Hlth Econ, 105 Victoria St, London SW1E 6QT, England
[2] Pfizer Inc, New York, NY USA
[3] NYU, Sch Med, New York, NY 10003 USA
[4] Univ Namur, Dept Pharm, NTHC, NARILIS,FUNDP, Namur, Belgium
关键词
adverse drug reactions reporting systems; masking; pharmacovigilance; postmarketing; product surveillance; signal; signal detection; COMPETITION BIAS; SIGNAL-DETECTION; GENERATION;
D O I
10.1177/2042098617704143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The lower bound of the 95% confidence interval of measures of disproportionality (Lower95CI) is widely used in signal detection. Masking is a statistical issue by which true signals of disproportionate reporting are hidden by the presence of other medicines. The primary objective of our study is to develop and validate a mathematical framework for assessing the masking effect of Lower95CI. Methods: We have developed our new algorithm based on the masking ratio (MR) developed for the measures of disproportionality. A MR for the Lower95CI (MRCI) is proposed. A simulation study to validate this algorithm was also conducted. Results: We have established the existence of a very close mathematical relation between MR and MRCI. For a given drug-event pair, the same product will be responsible for the highest masking effect with the measure of disproportionality and its Lower95CI. The extent of masking is likely to be very similar across the two methods. An important proportion of identical drug-event associations affected by the presence of an important masking effect is revealed by the unmasking exercise, whether the proportional reporting ratio (PRR) or its confidence interval are used. Conclusion: The detection of the masking effect of Lower95CI can be automated. The real benefits of this unmasking in terms of new true-positive signals (rate of true-positive/false-positive) or time gained by the revealing of signals using this method have not been fully assessed. These benefits should be demonstrated in the context of prospective studies.
引用
收藏
页码:231 / 244
页数:14
相关论文
共 21 条
[1]   Perspectives on the use of data mining in pharmacovigilance [J].
Almenoff, J ;
Tonning, JM ;
Gould, AL ;
Szarfman, A ;
Hauben, M ;
Ouellet-Hellstrom, R ;
Ball, R ;
Hornbuckle, K ;
Walsh, L ;
Yee, C ;
Sacks, ST ;
Yuen, N ;
Patadia, V ;
Blum, M ;
Johnston, M ;
Gerrits, C ;
Seifert, H ;
LaCroix, K .
DRUG SAFETY, 2005, 28 (11) :981-1007
[2]   Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data A Retrospective Evaluation of the Potential for Earlier Signalling [J].
Alvarez, Yolanda ;
Hidalgo, Ana ;
Maignen, Francois ;
Slattery, Jim .
DRUG SAFETY, 2010, 33 (06) :475-487
[3]  
[Anonymous], 2010, REPORT CIOMS WORKING
[4]   A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases [J].
Arnaud, Mickael ;
Salvo, Francesco ;
Ahmed, Ismail ;
Robinson, Philip ;
Moore, Nicholas ;
Begaud, Bernard ;
Tubert-Bitter, Pascale ;
Pariente, Antoine .
DRUG SAFETY, 2016, 39 (03) :251-260
[5]   Quantitative signal detection using spontaneous ADR reporting [J].
Bate, A. ;
Evans, S. J. W. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (06) :427-436
[6]  
COLLETT D, 2003, C&H TEXT STAT SCI, P1
[7]   Data mining in drug safety: Review of published threshold criteria for defining signals of disproportionate reporting [J].
Deshpande G. ;
Gogolak V. ;
Weiss Smith S. .
Pharmaceutical Medicine, 2010, 24 (1) :37-43
[8]   Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports [J].
Evans, SJW ;
Waller, PC ;
Davis, S .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) :483-486
[9]   Practical pharmacovigilance analysis strategies [J].
Gould, AL .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (07) :559-574
[10]   Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy [J].
Juhlin, Kristina ;
Ye, Xiaofei ;
Star, Kristina ;
Noren, G. Niklas .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (10) :1119-1129